XML 41 R25.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Leases | 12 Months Ended
--- | ---
Dec. 31, 2023
Leases [Abstract] |
Leases | Leases The Company has operating leases for real estate. The Company does not have any finance leases. During the year ended December 31, 2023, the Company recorded $4,245 of additional right-of-use assets related to a new lease for additional office space which commenced in May 2023 at its Menlo Park, California location. The Company will make total lease payments of $4,701 over the 36 month term of the new lease, which expires in May 2026. In addition, during the year ended December 31, 2023, the Company terminated the Company’s Cambridge, U.K. laboratory and office space lease as a result of the Company re-prioritizing its investments and financial resources towards the development of ivonescimab. This resulted in disposing the carrying value of the right-of use asset of $788, removing the related lease liability of $809, and there were no penalties charged for early termination of this lease. The Company recorded $2,860 of right-of-use assets during the year ended December 31, 2022 related to its Menlo Park, California location. The carrying value of the right-of-use assets as of December 31, 2023 and 2022 is $5,859 and $4,175, respectively. The elements of lease expense were as follows:
Lease Cost: |  | Year Ended December 31, 2023 |  | Year Ended December 31, 2022 |
Fixed lease costs |  | $ | 2,214 |  |  | $ | 1,384 |  |
Variable lease costs |  | 83 |  |  | 137 |  |
Short-term lease(1) |  | — |  |  | 31 |  |
Total lease cost |  | $ | 2,297 |  |  | $ | 1,552 |  |
(1) Short-term lease costs relate to the Company’s Cambridge, Massachusetts, United States office lease which the Company exited during fiscal year 2022. The weighted average discount rate and the weighted average remaining lease term were 6.6% and 2.4 years, respectively, as of December 31, 2023. The weighted average discount rate and the weighted average remaining lease term were 5.7% and 3.4 years, respectively, as of December 31, 2022. The Company made cash payments related to lease liabilities of $2,208 and $1,092 for the years ending December 31, 2023 and 2022 respectively. Future lease payments under non-cancelable leases as of December 31, 2023 are detailed as follows:
Year Ending December 31, |  |
2024 |  | $ | 2,810 |
2025 |  | 2,886 |
2026 |  | 893 |
2027 |  | — |
Total lease payments |  | 6,589 |
Less: imputed interest |  | 490 |
Total operating lease liabilities |  | $ | 6,099 |
Total operating lease liabilities balance sheet presentation: |  |
Current lease liabilities |  | $ | 2,809 |
Non-current lease liabilities |  | 3,290 |
|  | $ | 6,099 |
The Company signed a lease agreement on January 8, 2024 for executive office space for its new headquarters in Miami, Florida. The office space is approximately 9,000 square feet. The term of the lease is 64 months. Total payments for this office space is approximately $5,100 over the term of the lease. The table above excludes payments related to the lease signed in January 2024.

X
- References No definition available. + Details
Name: | us-gaap_LeasesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//842-20/tableOfContent + Details
Name: | us-gaap_LesseeOperatingLeasesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration